Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia

Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections

(2012) S.-H. Kim et al.   CLINICAL MICROBIOLOGY AND INFECTION

Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia

(2012) R. Álvarez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Emerging trends in candidemia: A higher incidence but a similar outcome

(2012) J. Fortún et al.   JOURNAL OF INFECTION

Time to positivity of blood cultures of different Candida species causing fungaemia

(2012) C.-C. Lai et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine inCandidaBloodstream Isolates from 15 Tertiary Hospitals in Korea

(2012) Sook-In Jung et al.   Annals of Laboratory Medicine

Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes

(2011) S. A. Grim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Time to blood culture positivity in Staphylococcus aureus bacteremia: Association with 30-day mortality

(2010) Joseph Kim et al.   JOURNAL OF INFECTION

The impact of delaying the initiation of appropriate antifungal treatment forCandidabloodstream infection

(2010) Maabo Kludze-Forson et al.   MEDICAL MYCOLOGY

The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock

(2009) Gourang P Patel et al.   AMERICAN JOURNAL OF THERAPEUTICS

Effect of Antifungal Therapy Timing on Mortality in Cancer Patients with Candidemia

(2009) Y. Taur et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America

(2009) Leonard A. Mermel et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study

(2009) C.-H. Liao et al.   CLINICAL MICROBIOLOGY AND INFECTION

SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS

(2009) Ji-Young Rhee et al.   SHOCK

Time to Blood Culture Positivity as a Marker for Catheter-Related Candidemia

(2008) R. Ben-Ami et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

(2007) Michael J. Klevay et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE